Variable | MLP reduction group (N = 38) | Allis reduction group (N = 40) | P value* |
---|---|---|---|
Demographic characteristics | |||
Age (yr) | 63.82 ± 14.91 | 58.72 ± 9.65 | 0.080 |
Male/female | 19/19 | 19/21 | 0.825 |
Weight (kg) | 64.65 ± 11.41 | 61.45 ± 11.85 | 0.227 |
Height (cm) | 164.45 ± 8.15 | 161.63 ± 8.69 | 0.086 |
BMI (kg/m2) | 24.12 ± 3.47 | 23.87 ± 3.82 | 0.762 |
Left/right/bilateral | 8/21/9 | 8/19/13 | 0.690 |
Diagnosis | |||
Primary THA | |||
ONFH | 19 | 18 | 0.658 |
OA | 4 | 2 | 0.360 |
RA | 3 | 5 | 0.503 |
DDH | 8 | 10 | 0.903 |
Revision THA | |||
Prosthetic Loosening | 2 | 2 | 0.958 |
Prosthetic Fracture | 2 | 1 | 0.526 |
Infection | 0 | 2 | 0.163 |
Comorbidities | |||
Hypertension | 14 | 16 | 0.774 |
Diabetes mellitus | 4 | 3 | 0.640 |
Osteoporosis | 10 | 5 | 0.122 |
COPD | 4 | 3 | 0.640 |
Preoperative hip function | |||
Flexion (deg) | 90.26 ± 29.15 | 93.50 ± 31.07 | 0.637 |
Abduction (deg) | 23.03 ± 10.81 | 24.75 ± 11.43 | 0.496 |
HHS score | 28.42 ± 14.55 | 36.53 ± 15.65 | 0.582 |
Duration of follow-up (yr) | 1.73 ± 1.94 | 1.60 ± 0.836 | 0.546 |